Fox Chase Temple Health

Fox Chase Cancer Center

This is your central portal for breaking news, the latest research and important updates from Fox Chase Cancer Center. Bookmark this page and check back often for updates.

In the Journals

Autologous HSCT extends PFS among young patients with mantle cell lymphoma

March 11, 2019
Consolidative autologous hematopoietic stem cell transplantation after induction chemotherapy significantly improved PFS among younger patients with…

Thomas Jefferson to negotiate with Temple for acquisition of Fox Chase Cancer Center

January 10, 2019
Thomas Jefferson University and Temple University have started negotiations regarding a potential acquisition of Fox Chase Cancer Center. Jefferson…

Fox Chase Cancer Center researcher receives American Cancer Society grant

December 16, 2018
American Cancer Society’s Pennsylvania/New Jersey Pay-If Research Council has awarded Jaye Gardiner, PhD, a $163,500 grant to support research…
Meeting NewsPerspective

Gut microbial diversity before stem cell transplantation may impact survival

December 13, 2018
SAN DIEGO — Higher gut microbial diversity was associated with improved survival in a multinational cohort of patients undergoing hematopoietic…
In the Journals Plus

Stereotactic radiosurgery comparable to surgical resection for local control of brain metastases

November 21, 2018
Stereotactic radiosurgery appeared comparable to surgical resection for controlling local brain metastases, according to an exploratory analysis of a…
Cover Story

Advances in myeloma treatments, diagnostics have specialists ‘talking about cure’

HemOnc Today, November 25, 2018
A decade ago, patients with newly diagnosed multiple myeloma typically survived 3 to 5 years. However, the development of highly effective therapies…
In the Journals PlusGuidelines

Guideline supports shorter radiation therapy option in prostate cancer

November 14, 2018
The American Society for Radiation Oncology, ASCO and the American Urological Association have published a guideline supporting moderately…

Recent advances push forward the field of molecular oncology

HemOnc Today, October 10, 2018
Wafik S. El-Deiry, MD, PhD, FACP
A number of recent advances in molecular oncology are noteworthy for our new regular column, which launched in September. Here is an overview of…

Translating an explosion of knowledge in molecular oncology

HemOnc Today, September 10, 2018
Wafik S. El-Deiry, MD, PhD, FACP
There have been many advances in the molecular analysis of cancer in recent years, with an explosion of knowledge that can be daunting and rapid…

Fox Chase Cancer Center appoints general surgery division chief

September 9, 2018
Jeffrey Farma, MD, has been appointed chief of the division of general surgery within the department of surgery at Fox Chase Cancer Center. Farma, a…

Erroneous reporting vs. erroneous interpretation of liquid biopsy results

HemOnc Today, August 10, 2018
Wafik S. El-Deiry, MD, PhD, FACP
As the co-chair of the oral abstract session on tumor biology at this year’s ASCO Annual Meeting, I was particularly looking forward to a…

Fox Chase Cancer Center appoints assistant professor

August 8, 2018
Kristen Whitaker, MD, has been appointed assistant professor in the department of clinical genetics at Fox Chase Cancer Center. Whitaker will treat…

American Society for Radiation Oncology members receive fellow designation

July 28, 2018
American Society for Radiation Oncology designated 35 members as ASTRO fellows. The honorees will be recognized during the society’s annual…
In the Journals PlusPerspective

BRAF V600E mutations linked to worse survival in metastatic colorectal cancer

July 24, 2018
Harboring a BRAF V600E mutation appeared associated with a poorer prognosis and greater risk for recurrence after curative-intent resection compared…
In the Journals PlusPerspective

Prevalence of clonal hematopoiesis may confound tumor-only genomic profiling results

July 6, 2018
Clonal hematopoiesis-related mutations appeared to be misinterpreted as solid tumors mutations when tumor-only sequencing was used for a variety of…
In the Journals PlusPerspective

Germline mutations common in advanced renal cell carcinoma

July 5, 2018
A substantial proportion of patients with advanced renal cell carcinoma harbored germline mutations, many of whom were not eligible for genetic…
Meeting News

HemOnc Today honors Next Gen Innovators at ASCO

HemOnc Today, June 25, 2018
HemOnc Today unveiled its second class of Next Gen Innovators during ASCO Annual Meeting. The publication’s 71 Next Gen Innovators —…
Meeting NewsPerspective

Nivolumab plus chemotherapy prolongs PFS in lung cancer with PD-L1 less than 1%

June 12, 2018
CHICAGO — Therapy with nivolumab plus chemotherapy improved PFS compared with chemotherapy alone among patients with newly diagnosed advanced…

Cancer centers join forces to eliminate HPV-related cancers

June 7, 2018
The nation’s 70 NCI-designated cancer centers issued a joint statement today calling for increased gender-neutral HPV vaccination and…
Meeting NewsPerspective

Adjuvant FOLFIRINOX new standard of care for pancreatic cancer

June 4, 2018
CHICAGO — Adjuvant FOLFIRINOX chemotherapy improved OS and PFS compared with gemcitabine among patients with surgically removed nonmetastatic…